Fig. 3From: Upregulation of SLC2A3 gene and prognosis in colorectal carcinoma: analysis of TCGA dataKaplan-Meier survival analysis of colorectal cancer patients stratified by SLC2A1 expression levels in Discovery set and Validation set. Disease-free survival curve of patients in Discovery set (a) and Validation Set (b) with high versus low SLC2A1 expression levels. P-values for significance of difference between high and low expression were calculated using the log-rank testBack to article page